Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma
一项随机、双盲、安慰剂对照的全球III期临床试验,评估Talimogene Laherparepvec联合帕博利珠单抗治疗晚期黑色素瘤的疗效
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.22.00343
Chesney, Jason A; Ribas, Antoni; Long, Georgina V; Kirkwood, John M; Dummer, Reinhard; Puzanov, Igor; Hoeller, Christoph; Gajewski, Thomas F; Gutzmer, Ralf; Rutkowski, Piotr; Demidov, Lev; Arenberger, Petr; Shin, Sang Joon; Ferrucci, Pier Francesco; Haydon, Andrew; Hyngstrom, John; van Thienen, Johannes V; Haferkamp, Sebastian; Guilera, Josep Malvehy; Rapoport, Bernardo Leon; VanderWalde, Ari; Diede, Scott J; Anderson, James R; Treichel, Sheryl; Chan, Edward L; Bhatta, Sumita; Gansert, Jennifer; Hodi, Frank Stephen; Gogas, Helen